- Home
- COCP
as of 12-12-2025 2:33pm EST
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 14.1M | IPO Year: | N/A |
| Target Price: | $6.00 | AVG Volume (30 days): | 56.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.90 - $3.26 | Next Earning Date: | 11-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered COCP Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Cocrystal Pharma Inc. (COCP)
Director, 10% Owner
Avg Cost/Share
$1.00
Shares
4,000
Total Value
$3,975.00
Owned After
1,701,051
Director, 10% Owner
Avg Cost/Share
$0.94
Shares
20,000
Total Value
$18,812.00
Owned After
1,701,051
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | COCP | Director, 10% Owner | Nov 26, 2025 | Buy | $1.00 | 4,000 | $3,975.00 | 1,701,051 | |
| FROST PHILLIP MD ET AL | COCP | Director, 10% Owner | Nov 25, 2025 | Buy | $0.94 | 20,000 | $18,812.00 | 1,701,051 |
Compare COCP vs Leading Stocks
See how COCP stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "COCP Cocrystal Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.